Kliničke studije za Umor u državi Kalifornija
6 studija za Umor traži sudionike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Službeni tekst studije (engleski)
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- UC San Diego Medical Center - Encinitas, Encinitas
- Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- UCI Health - Irvine, Irvine
- i još 14
U tijeku regrutacijaFaza 2/3
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT06989437A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Stanford Center for Sleep Medicine, Redwood City
- Trial Site Solutions, San Ramon
- Santa Monica Clinical Trials, Santa Monica
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Los Angeles
U tijeku regrutacijaFaza 3
Od 18 do 70 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT07455383A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy
- West Coast Pulmonary & Sleep Disorders Center, Lancaster
- Santa Monica Clinical Trials, Los Angeles
- Stanford Center for Sleep Sciences and Medicine, Redwood City
- i još 2
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 27. kol 2026. · NCT07675135Biofield Therapy for the Support of Immunotherapy-related Symptoms Among Adult Cancer Patients - A Pilot Study
- UCI Health Susan Samueli Integrative Health Institute, Irvine
- UCI Health, Orange
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 10. srp 2026. · NCT07581080Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- University of California Davis Health, Sacramento
U tijeku regrutacijaFaza 2
Od 21 do 85 godina · Oba spola · Ažurirano 6. svi 2026. · NCT04984226Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.